Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Asthma (13)
  • Basic immunology (1)
  • Biologicals (10)
  • x Biomarkers (6)
  • COVID19 (1)
  • Drug allergy (3)
  • ENT (5)
Poster available until
Poster categories
keywords
Session Reference
  • L-TPS02 (6)
  • L-TPS07 (3)
  • L-TPS08 (1)
  • L-TPS09 (4)
  • L-TPS15 (1)
  • L-TPS18 (1)
  • L-TPS21 (2)
  • TPS02 (6)
  • TPS03 (1)
  • TPS06 (1)
  • TPS17 (4)
  • TPS19 (1)
  • TPS37 (1)
  • TPS44 (2)
  • TPS45 (1)
  • TPS47 (1)
  • TPS51 (1)
  • x TPS55 (6)
  • TPS56 (3)
  • TPS57 (2)
  • TPS63 (2)
  • TPS67 (2)
  • TPS68 (19)
  • TPS75 (1)
6 results
Thumbnail

- D3.100 - Risk Factors and Biomarkers for COVID-19 and Allergic Diseases

Thumbnail

- D3.103 - Impact of aspirin-induced bronchospasm on the in vitro Aspirin Hypersensitivity Diagnostic Index in the patients with Aspirin Exacerbated Respiratory Disease

Thumbnail

- D3.108 - PTGDR2 Blood Expression as a Potential Biomarker for Predicting Super-Response to IL-5-Targeted Therapies in Severe Asthma

Thumbnail

- D3.111 - Lymphocyte profile and asthma control during the treatment with benralizumab in real life

Thumbnail

- D3.112 - Role of nasal cytology in patients with bronchial asthma

Thumbnail

- D3.99 - Early Real-World Outcomes of Tezepelumab in Severe Asthma Patients Unresponsive to Prior Biologics

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM